Revicki, D A <br/><br/>
Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3.  [electronic resource] 

 -  Antiviral therapy  1999 
 - 35-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1359-6535 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>HIV Infections--drug therapy<br/>Humans<br/>Quality of Life<br/>Saquinavir--administration & dosage<br/>Zalcitabine--administration & dosage